Skip to search formSkip to main contentSkip to account menu

NSC 338258

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ellipticines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myeloma
High-risk multiple myeloma can be correlated with amplification and overexpression of the cell cycle regulator CKS1B. Herein, we… 
2005
2005
The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.
We recently discovered that amplification and overexpression of the CKS1B gene, which regulates the ubiquitination and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)